Cargando…
Effects of a novel ANLN E841K mutation associated with SRNS on podocytes and its mechanism
BACKGROUND: Steroid-resistant nephrotic syndrome (SRNS) is characterized by unrelieved proteinuria after an initial 4–8 weeks of glucocorticoid therapy. Genes in podocytes play an important role in causing SRNS. OBJECTIVE: This study aimed to report a pathogenic mutation in SRNS patients and investi...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10644598/ https://www.ncbi.nlm.nih.gov/pubmed/37957688 http://dx.doi.org/10.1186/s12964-023-01218-w |
_version_ | 1785147262845845504 |
---|---|
author | Lin, Li Ye, Yuhong Fu, Haidong Gu, Weizhong Zhao, Manli Sun, Jingmiao Cao, Zhongkai Huang, Guoping Xie, Yi Liu, Fei Li, Lu Li, Qiuyu Mao, Jianhua Hu, Lidan |
author_facet | Lin, Li Ye, Yuhong Fu, Haidong Gu, Weizhong Zhao, Manli Sun, Jingmiao Cao, Zhongkai Huang, Guoping Xie, Yi Liu, Fei Li, Lu Li, Qiuyu Mao, Jianhua Hu, Lidan |
author_sort | Lin, Li |
collection | PubMed |
description | BACKGROUND: Steroid-resistant nephrotic syndrome (SRNS) is characterized by unrelieved proteinuria after an initial 4–8 weeks of glucocorticoid therapy. Genes in podocytes play an important role in causing SRNS. OBJECTIVE: This study aimed to report a pathogenic mutation in SRNS patients and investigate its effects on podocytes, as well as the pathogenic mechanism. METHODS: We screened out a novel mutation by using whole-exon sequencing in the SRNS cohort and verified it via Sanger sequencing. Conservative analysis and bioinformatic analysis were used to predict the pathogenicity of the mutation. In vitro, stable podocyte cell lines were constructed to detect the effect of the mutation on the function of the podocyte. Moreover, an in vivo mouse model of podocyte ANLN gene knockout (ANLN(podKO)) was used to confirm clinical manifestations. Transcriptome analysis was performed to identify differential gene expression and related signaling pathways. RESULTS: ANLN E841K was screened from three unrelated families. ANLN E841K occurred in the functional domain and was predicted to be harmful. The pathological type of A-II-1 renal biopsy was minimal change disease, and the expression of ANLN was decreased. Cells in the mutation group showed disordered cytoskeleton, faster cell migration, decreased adhesion, increased endocytosis, slower proliferation, increased apoptosis, and weakened interaction with CD2 association protein. ANLN(podKO) mice exhibited more obvious proteinuria, more severe mesangial proliferation, glomerular atrophy, foot process fusion, and increased tissue apoptosis levels than ANLN(flox/flox) mice after tail vein injection of adriamycin. Upregulated differentially expressed genes in cells of the mutation group were mainly enriched in the PI3K-AKT pathway. CONCLUSION: The novel mutation known as ANLN E841K affected the function of the ANLN protein by activating the PI3K/AKT/mTOR/apoptosis pathway, thus resulting in structural and functional changes in podocytes. Our study indicated that ANLN played a vital role in maintaining the normal function of podocytes. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12964-023-01218-w. |
format | Online Article Text |
id | pubmed-10644598 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-106445982023-11-13 Effects of a novel ANLN E841K mutation associated with SRNS on podocytes and its mechanism Lin, Li Ye, Yuhong Fu, Haidong Gu, Weizhong Zhao, Manli Sun, Jingmiao Cao, Zhongkai Huang, Guoping Xie, Yi Liu, Fei Li, Lu Li, Qiuyu Mao, Jianhua Hu, Lidan Cell Commun Signal Research BACKGROUND: Steroid-resistant nephrotic syndrome (SRNS) is characterized by unrelieved proteinuria after an initial 4–8 weeks of glucocorticoid therapy. Genes in podocytes play an important role in causing SRNS. OBJECTIVE: This study aimed to report a pathogenic mutation in SRNS patients and investigate its effects on podocytes, as well as the pathogenic mechanism. METHODS: We screened out a novel mutation by using whole-exon sequencing in the SRNS cohort and verified it via Sanger sequencing. Conservative analysis and bioinformatic analysis were used to predict the pathogenicity of the mutation. In vitro, stable podocyte cell lines were constructed to detect the effect of the mutation on the function of the podocyte. Moreover, an in vivo mouse model of podocyte ANLN gene knockout (ANLN(podKO)) was used to confirm clinical manifestations. Transcriptome analysis was performed to identify differential gene expression and related signaling pathways. RESULTS: ANLN E841K was screened from three unrelated families. ANLN E841K occurred in the functional domain and was predicted to be harmful. The pathological type of A-II-1 renal biopsy was minimal change disease, and the expression of ANLN was decreased. Cells in the mutation group showed disordered cytoskeleton, faster cell migration, decreased adhesion, increased endocytosis, slower proliferation, increased apoptosis, and weakened interaction with CD2 association protein. ANLN(podKO) mice exhibited more obvious proteinuria, more severe mesangial proliferation, glomerular atrophy, foot process fusion, and increased tissue apoptosis levels than ANLN(flox/flox) mice after tail vein injection of adriamycin. Upregulated differentially expressed genes in cells of the mutation group were mainly enriched in the PI3K-AKT pathway. CONCLUSION: The novel mutation known as ANLN E841K affected the function of the ANLN protein by activating the PI3K/AKT/mTOR/apoptosis pathway, thus resulting in structural and functional changes in podocytes. Our study indicated that ANLN played a vital role in maintaining the normal function of podocytes. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12964-023-01218-w. BioMed Central 2023-11-13 /pmc/articles/PMC10644598/ /pubmed/37957688 http://dx.doi.org/10.1186/s12964-023-01218-w Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Lin, Li Ye, Yuhong Fu, Haidong Gu, Weizhong Zhao, Manli Sun, Jingmiao Cao, Zhongkai Huang, Guoping Xie, Yi Liu, Fei Li, Lu Li, Qiuyu Mao, Jianhua Hu, Lidan Effects of a novel ANLN E841K mutation associated with SRNS on podocytes and its mechanism |
title | Effects of a novel ANLN E841K mutation associated with SRNS on podocytes and its mechanism |
title_full | Effects of a novel ANLN E841K mutation associated with SRNS on podocytes and its mechanism |
title_fullStr | Effects of a novel ANLN E841K mutation associated with SRNS on podocytes and its mechanism |
title_full_unstemmed | Effects of a novel ANLN E841K mutation associated with SRNS on podocytes and its mechanism |
title_short | Effects of a novel ANLN E841K mutation associated with SRNS on podocytes and its mechanism |
title_sort | effects of a novel anln e841k mutation associated with srns on podocytes and its mechanism |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10644598/ https://www.ncbi.nlm.nih.gov/pubmed/37957688 http://dx.doi.org/10.1186/s12964-023-01218-w |
work_keys_str_mv | AT linli effectsofanovelanlne841kmutationassociatedwithsrnsonpodocytesanditsmechanism AT yeyuhong effectsofanovelanlne841kmutationassociatedwithsrnsonpodocytesanditsmechanism AT fuhaidong effectsofanovelanlne841kmutationassociatedwithsrnsonpodocytesanditsmechanism AT guweizhong effectsofanovelanlne841kmutationassociatedwithsrnsonpodocytesanditsmechanism AT zhaomanli effectsofanovelanlne841kmutationassociatedwithsrnsonpodocytesanditsmechanism AT sunjingmiao effectsofanovelanlne841kmutationassociatedwithsrnsonpodocytesanditsmechanism AT caozhongkai effectsofanovelanlne841kmutationassociatedwithsrnsonpodocytesanditsmechanism AT huangguoping effectsofanovelanlne841kmutationassociatedwithsrnsonpodocytesanditsmechanism AT xieyi effectsofanovelanlne841kmutationassociatedwithsrnsonpodocytesanditsmechanism AT liufei effectsofanovelanlne841kmutationassociatedwithsrnsonpodocytesanditsmechanism AT lilu effectsofanovelanlne841kmutationassociatedwithsrnsonpodocytesanditsmechanism AT liqiuyu effectsofanovelanlne841kmutationassociatedwithsrnsonpodocytesanditsmechanism AT maojianhua effectsofanovelanlne841kmutationassociatedwithsrnsonpodocytesanditsmechanism AT hulidan effectsofanovelanlne841kmutationassociatedwithsrnsonpodocytesanditsmechanism |